{
  "input": {
    "mode": "revise",
    "query": {
      "entity": "Epileptic encephalopathy",
      "relation": "contraindication"
    },
    "tegraph_snapshot": {
      "nodes": [
        {
          "id": "n_phenytoin",
          "type": "Drug",
          "label": "Phenytoin",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_carbamazepine",
          "type": "Drug",
          "label": "Carbamazepine",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_valproate",
          "type": "Drug",
          "label": "Valproate",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_lamotrigine",
          "type": "Drug",
          "label": "Lamotrigine",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_topiramate",
          "type": "Drug",
          "label": "Topiramate",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_oxidcarbazepine",
          "type": "Drug",
          "label": "Oxcarbazepine",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_lacosamide",
          "type": "Drug",
          "label": "Lacosamide",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_zonisamide",
          "type": "Drug",
          "label": "Zonisamide",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_pregabalin",
          "type": "Drug",
          "label": "Pregabalin",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_gabapentin",
          "type": "Drug",
          "label": "Gabapentin",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_rufinamide",
          "type": "Drug",
          "label": "Rufinamide",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_clobazam",
          "type": "Drug",
          "label": "Clobazam",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_epileptic_encephalopathy",
          "type": "Disease",
          "label": "Epileptic Encephalopathy",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_ot_phenytoin",
          "type": "Target",
          "label": "Off-target effect for Phenytoin",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ot_carbamazepine",
          "type": "Target",
          "label": "Off-target effect for Carbamazepine",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ot_valproate",
          "type": "Target",
          "label": "Off-target effect for Valproate",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ot_lamotrigine",
          "type": "Target",
          "label": "Off-target effect for Lamotrigine",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ot_topiramate",
          "type": "Target",
          "label": "Off-target effect for Topiramate",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ot_oxcarbazepine",
          "type": "Target",
          "label": "Off-target effect for Oxcarbazepine",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ot_lacosamide",
          "type": "Target",
          "label": "Off-target effect for Lacosamide",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ot_zonisamide",
          "type": "Target",
          "label": "Off-target effect for Zonisamide",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ot_pregabalin",
          "type": "Target",
          "label": "Off-target effect for Pregabalin",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ot_gabapentin",
          "type": "Target",
          "label": "Off-target effect for Gabapentin",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ot_rufinamide",
          "type": "Target",
          "label": "Off-target effect for Rufinamide",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ot_clobazam",
          "type": "Target",
          "label": "Off-target effect for Clobazam",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_rp",
          "type": "Pathway",
          "label": "Risk Pathway for adverse effects",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_adv",
          "type": "Phenotype",
          "label": "Adverse effects in Epileptic encephalopathy",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "H1",
          "type": "Hypothesis",
          "label": "Phenytoin",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "drug_phenytoin",
          "type": "Drug",
          "label": "Phenytoin",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "H2",
          "type": "Hypothesis",
          "label": "Carbamazepine",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "drug_carbamazepine",
          "type": "Drug",
          "label": "Carbamazepine",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "H3",
          "type": "Hypothesis",
          "label": "Valproate",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "drug_valproate",
          "type": "Drug",
          "label": "Valproate",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "H4",
          "type": "Hypothesis",
          "label": "Lamotrigine",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "drug_lamotrigine",
          "type": "Drug",
          "label": "Lamotrigine",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "H5",
          "type": "Hypothesis",
          "label": "Topiramate",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "drug_topiramate",
          "type": "Drug",
          "label": "Topiramate",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "H6",
          "type": "Hypothesis",
          "label": "Oxcarbazepine",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "drug_oxcarbazepine",
          "type": "Drug",
          "label": "Oxcarbazepine",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "H7",
          "type": "Hypothesis",
          "label": "Lacosamide",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "drug_lacosamide",
          "type": "Drug",
          "label": "Lacosamide",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "H8",
          "type": "Hypothesis",
          "label": "Zonisamide",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "drug_zonisamide",
          "type": "Drug",
          "label": "Zonisamide",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "H9",
          "type": "Hypothesis",
          "label": "Pregabalin",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "drug_pregabalin",
          "type": "Drug",
          "label": "Pregabalin",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "H10",
          "type": "Hypothesis",
          "label": "Gabapentin",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "drug_gabapentin",
          "type": "Drug",
          "label": "Gabapentin",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "H11",
          "type": "Hypothesis",
          "label": "Rufinamide",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "drug_rufinamide",
          "type": "Drug",
          "label": "Rufinamide",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "H12",
          "type": "Hypothesis",
          "label": "Clobazam",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "drug_clobazam",
          "type": "Drug",
          "label": "Clobazam",
          "attrs": {
            "agent": "Proponent"
          }
        }
      ],
      "edges": [
        {
          "source": "n_phenytoin",
          "target": "n_epileptic_encephalopathy",
          "relation": "contraindication",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "临床常识，重度癫痫相关药物的禁忌"
        },
        {
          "source": "n_carbamazepine",
          "target": "n_epileptic_encephalopathy",
          "relation": "contraindication",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "临床常识，重度癫痫相关药物的禁忌"
        },
        {
          "source": "n_valproate",
          "target": "n_epileptic_encephalopathy",
          "relation": "contraindication",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "临床常识，重度癫痫相关药物的禁忌"
        },
        {
          "source": "n_lamotrigine",
          "target": "n_epileptic_encephalopathy",
          "relation": "contraindication",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "临床常识，重度癫痫相关药物的禁忌"
        },
        {
          "source": "n_topiramate",
          "target": "n_epileptic_encephalopathy",
          "relation": "contraindication",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "临床常识，重度癫痫相关药物的禁忌"
        },
        {
          "source": "n_oxidcarbazepine",
          "target": "n_epileptic_encephalopathy",
          "relation": "contraindication",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "临床常识，重度癫痫相关药物的禁忌"
        },
        {
          "source": "n_lacosamide",
          "target": "n_epileptic_encephalopathy",
          "relation": "contraindication",
          "weight": 0.6,
          "agent": "Proponent",
          "rationale": "临床常识，重度癫痫相关药物的禁忌"
        },
        {
          "source": "n_zonisamide",
          "target": "n_epileptic_encephalopathy",
          "relation": "contraindication",
          "weight": 0.6,
          "agent": "Proponent",
          "rationale": "临床常识，重度癫痫相关药物的禁忌"
        },
        {
          "source": "n_pregabalin",
          "target": "n_epileptic_encephalopathy",
          "relation": "contraindication",
          "weight": 0.5,
          "agent": "Proponent",
          "rationale": "临床常识，重度癫痫相关药物的禁忌"
        },
        {
          "source": "n_gabapentin",
          "target": "n_epileptic_encephalopathy",
          "relation": "contraindication",
          "weight": 0.5,
          "agent": "Proponent",
          "rationale": "临床常识，重度癫痫相关药物的禁忌"
        },
        {
          "source": "n_rufinamide",
          "target": "n_epileptic_encephalopathy",
          "relation": "contraindication",
          "weight": 0.4,
          "agent": "Proponent",
          "rationale": "临床常识，重度癫痫相关药物的禁忌"
        },
        {
          "source": "n_clobazam",
          "target": "n_epileptic_encephalopathy",
          "relation": "contraindication",
          "weight": 0.4,
          "agent": "Proponent",
          "rationale": "临床常识，重度癫痫相关药物的禁忌"
        },
        {
          "source": "drug_phenytoin",
          "target": "n_ot_phenytoin",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能的靶外作用影响"
        },
        {
          "source": "drug_carbamazepine",
          "target": "n_ot_carbamazepine",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能的靶外作用影响"
        },
        {
          "source": "drug_valproate",
          "target": "n_ot_valproate",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能的靶外作用影响"
        },
        {
          "source": "drug_lamotrigine",
          "target": "n_ot_lamotrigine",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能的靶外作用影响"
        },
        {
          "source": "drug_topiramate",
          "target": "n_ot_topiramate",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能的靶外作用影响"
        },
        {
          "source": "drug_oxcarbazepine",
          "target": "n_ot_oxcarbazepine",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能的靶外作用影响"
        },
        {
          "source": "drug_lacosamide",
          "target": "n_ot_lacosamide",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能的靶外作用影响"
        },
        {
          "source": "drug_zonisamide",
          "target": "n_ot_zonisamide",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能的靶外作用影响"
        },
        {
          "source": "drug_pregabalin",
          "target": "n_ot_pregabalin",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能的靶外作用影响"
        },
        {
          "source": "drug_gabapentin",
          "target": "n_ot_gabapentin",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能的靶外作用影响"
        },
        {
          "source": "drug_rufinamide",
          "target": "n_ot_rufinamide",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能的靶外作用影响"
        },
        {
          "source": "drug_clobazam",
          "target": "n_ot_clobazam",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能的靶外作用影响"
        },
        {
          "source": "n_ot_phenytoin",
          "target": "n_rp",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "风险通路关联"
        },
        {
          "source": "n_ot_carbamazepine",
          "target": "n_rp",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "风险通路关联"
        },
        {
          "source": "n_ot_valproate",
          "target": "n_rp",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "风险通路关联"
        },
        {
          "source": "n_ot_lamotrigine",
          "target": "n_rp",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "风险通路关联"
        },
        {
          "source": "n_ot_topiramate",
          "target": "n_rp",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "风险通路关联"
        },
        {
          "source": "n_ot_oxcarbazepine",
          "target": "n_rp",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "风险通路关联"
        },
        {
          "source": "n_ot_lacosamide",
          "target": "n_rp",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "风险通路关联"
        },
        {
          "source": "n_ot_zonisamide",
          "target": "n_rp",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "风险通路关联"
        },
        {
          "source": "n_ot_pregabalin",
          "target": "n_rp",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "风险通路关联"
        },
        {
          "source": "n_ot_gabapentin",
          "target": "n_rp",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "风险通路关联"
        },
        {
          "source": "n_ot_rufinamide",
          "target": "n_rp",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "风险通路关联"
        },
        {
          "source": "n_ot_clobazam",
          "target": "n_rp",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "风险通路关联"
        },
        {
          "source": "n_rp",
          "target": "n_adv",
          "relation": "causes",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "导致不良表型"
        },
        {
          "source": "n_adv",
          "target": "H1",
          "relation": "refutes",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "若风险成立将抵消净获益"
        },
        {
          "source": "n_adv",
          "target": "H2",
          "relation": "refutes",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "若风险成立将抵消净获益"
        },
        {
          "source": "n_adv",
          "target": "H3",
          "relation": "refutes",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "若风险成立将抵消净获益"
        },
        {
          "source": "n_adv",
          "target": "H4",
          "relation": "refutes",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "若风险成立将抵消净获益"
        },
        {
          "source": "n_adv",
          "target": "H5",
          "relation": "refutes",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "若风险成立将抵消净获益"
        },
        {
          "source": "n_adv",
          "target": "H6",
          "relation": "refutes",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "若风险成立将抵消净获益"
        },
        {
          "source": "n_adv",
          "target": "H7",
          "relation": "refutes",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "若风险成立将抵消净获益"
        },
        {
          "source": "n_adv",
          "target": "H8",
          "relation": "refutes",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "若风险成立将抵消净获益"
        },
        {
          "source": "n_adv",
          "target": "H9",
          "relation": "refutes",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "若风险成立将抵消净获益"
        },
        {
          "source": "n_adv",
          "target": "H10",
          "relation": "refutes",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "若风险成立将抵消净获益"
        },
        {
          "source": "n_adv",
          "target": "H11",
          "relation": "refutes",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "若风险成立将抵消净获益"
        },
        {
          "source": "n_adv",
          "target": "H12",
          "relation": "refutes",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "若风险成立将抵消净获益"
        }
      ],
      "round_index": 3
    },
    "history": {
      "round": 3,
      "last_scores": [
        {
          "hypothesis_id": "H1",
          "score": 0.38,
          "components": {
            "mechanism_fit": 0.8,
            "class_prior": 0.5,
            "pk_pd_feasibility": 0.7,
            "indication_plausibility": 0.5,
            "safety_risk": 0.5,
            "graph_bonus": 0,
            "conflict_penalty": 0.8
          },
          "graph_signals": {
            "support_weight": 0.8,
            "contradiction_weight": 0.8,
            "mechanistic_connectivity": false,
            "path_disjointness": 1,
            "conflict_hotspots": [
              {
                "topic": "Adverse effects in Epileptic encephalopathy",
                "pro": [
                  "n_phenytoin"
                ],
                "con": [
                  "H1"
                ]
              }
            ]
          },
          "rationales": {
            "mechanism_fit": [
              "支持 Phenytoin 禁忌用于重度癫痫，文献支持"
            ],
            "safety_risk": [
              "Skeptic 指出风险路径与不良反应之间的关系"
            ]
          },
          "confidence": "medium",
          "uncertainties": [
            "需要更多证据确认具体禁忌机制",
            "Phenytoin 的长期安全性数据不足"
          ]
        },
        {
          "hypothesis_id": "H2",
          "score": 0.38,
          "components": {
            "mechanism_fit": 0.8,
            "class_prior": 0.5,
            "pk_pd_feasibility": 0.7,
            "indication_plausibility": 0.5,
            "safety_risk": 0.5,
            "graph_bonus": 0,
            "conflict_penalty": 0.8
          },
          "graph_signals": {
            "support_weight": 0.8,
            "contradiction_weight": 0.8,
            "mechanistic_connectivity": false,
            "path_disjointness": 1,
            "conflict_hotspots": [
              {
                "topic": "Adverse effects in Epileptic encephalopathy",
                "pro": [
                  "n_carbamazepine"
                ],
                "con": [
                  "H2"
                ]
              }
            ]
          },
          "rationales": {
            "mechanism_fit": [
              "支持 Carbamazepine 禁忌用于重度癫痫，文献支持"
            ],
            "safety_risk": [
              "Skeptic 指出风险路径与不良反应之间的关系"
            ]
          },
          "confidence": "medium",
          "uncertainties": [
            "需要更多证据确认具体禁忌机制",
            "Carbamazepine 的长期安全性数据不足"
          ]
        },
        {
          "hypothesis_id": "H3",
          "score": 0.38,
          "components": {
            "mechanism_fit": 0.8,
            "class_prior": 0.5,
            "pk_pd_feasibility": 0.7,
            "indication_plausibility": 0.5,
            "safety_risk": 0.5,
            "graph_bonus": 0,
            "conflict_penalty": 0.8
          },
          "graph_signals": {
            "support_weight": 0.8,
            "contradiction_weight": 0.8,
            "mechanistic_connectivity": false,
            "path_disjointness": 1,
            "conflict_hotspots": [
              {
                "topic": "Adverse effects in Epileptic encephalopathy",
                "pro": [
                  "n_valproate"
                ],
                "con": [
                  "H3"
                ]
              }
            ]
          },
          "rationales": {
            "mechanism_fit": [
              "支持 Valproate 禁忌用于重度癫痫，文献支持"
            ],
            "safety_risk": [
              "Skeptic 指出风险路径与不良反应之间的关系"
            ]
          },
          "confidence": "medium",
          "uncertainties": [
            "需要更多证据确认具体禁忌机制",
            "Valproate 的长期安全性数据不足"
          ]
        },
        {
          "hypothesis_id": "H4",
          "score": 0.38,
          "components": {
            "mechanism_fit": 0.8,
            "class_prior": 0.5,
            "pk_pd_feasibility": 0.7,
            "indication_plausibility": 0.5,
            "safety_risk": 0.5,
            "graph_bonus": 0,
            "conflict_penalty": 0.8
          },
          "graph_signals": {
            "support_weight": 0.8,
            "contradiction_weight": 0.8,
            "mechanistic_connectivity": false,
            "path_disjointness": 1,
            "conflict_hotspots": [
              {
                "topic": "Adverse effects in Epileptic encephalopathy",
                "pro": [
                  "n_lamotrigine"
                ],
                "con": [
                  "H4"
                ]
              }
            ]
          },
          "rationales": {
            "mechanism_fit": [
              "支持 Lamotrigine 禁忌用于重度癫痫，文献支持"
            ],
            "safety_risk": [
              "Skeptic 指出风险路径与不良反应之间的关系"
            ]
          },
          "confidence": "medium",
          "uncertainties": [
            "需要更多证据确认具体禁忌机制",
            "Lamotrigine 的长期安全性数据不足"
          ]
        },
        {
          "hypothesis_id": "H5",
          "score": 0.38,
          "components": {
            "mechanism_fit": 0.8,
            "class_prior": 0.5,
            "pk_pd_feasibility": 0.7,
            "indication_plausibility": 0.5,
            "safety_risk": 0.5,
            "graph_bonus": 0,
            "conflict_penalty": 0.8
          },
          "graph_signals": {
            "support_weight": 0.8,
            "contradiction_weight": 0.8,
            "mechanistic_connectivity": false,
            "path_disjointness": 1,
            "conflict_hotspots": [
              {
                "topic": "Adverse effects in Epileptic encephalopathy",
                "pro": [
                  "n_topiramate"
                ],
                "con": [
                  "H5"
                ]
              }
            ]
          },
          "rationales": {
            "mechanism_fit": [
              "支持 Topiramate 禁忌用于重度癫痫，文献支持"
            ],
            "safety_risk": [
              "Skeptic 指出风险路径与不良反应之间的关系"
            ]
          },
          "confidence": "medium",
          "uncertainties": [
            "需要更多证据确认具体禁忌机制",
            "Topiramate 的长期安全性数据不足"
          ]
        },
        {
          "hypothesis_id": "H6",
          "score": 0.36,
          "components": {
            "mechanism_fit": 0.7,
            "class_prior": 0.5,
            "pk_pd_feasibility": 0.7,
            "indication_plausibility": 0.5,
            "safety_risk": 0.5,
            "graph_bonus": 0,
            "conflict_penalty": 0.8
          },
          "graph_signals": {
            "support_weight": 0.7,
            "contradiction_weight": 0.8,
            "mechanistic_connectivity": false,
            "path_disjointness": 1,
            "conflict_hotspots": [
              {
                "topic": "Adverse effects in Epileptic encephalopathy",
                "pro": [
                  "n_oxidcarbazepine"
                ],
                "con": [
                  "H6"
                ]
              }
            ]
          },
          "rationales": {
            "mechanism_fit": [
              "支持 Oxcarbazepine 禁忌用于重度癫痫，文献支持"
            ],
            "safety_risk": [
              "Skeptic 指出风险路径与不良反应之间的关系"
            ]
          },
          "confidence": "medium",
          "uncertainties": [
            "需要更多证据确认具体禁忌机制",
            "Oxcarbazepine 的长期安全性数据不足"
          ]
        },
        {
          "hypothesis_id": "H7",
          "score": 0.34,
          "components": {
            "mechanism_fit": 0.6,
            "class_prior": 0.5,
            "pk_pd_feasibility": 0.7,
            "indication_plausibility": 0.5,
            "safety_risk": 0.5,
            "graph_bonus": 0,
            "conflict_penalty": 0.8
          },
          "graph_signals": {
            "support_weight": 0.6,
            "contradiction_weight": 0.8,
            "mechanistic_connectivity": false,
            "path_disjointness": 1,
            "conflict_hotspots": [
              {
                "topic": "Adverse effects in Epileptic encephalopathy",
                "pro": [
                  "n_lacosamide"
                ],
                "con": [
                  "H7"
                ]
              }
            ]
          },
          "rationales": {
            "mechanism_fit": [
              "支持 Lacosamide 禁忌用于重度癫痫，文献支持"
            ],
            "safety_risk": [
              "Skeptic 指出风险路径与不良反应之间的关系"
            ]
          },
          "confidence": "medium",
          "uncertainties": [
            "需要更多证据确认具体禁忌机制",
            "Lacosamide 的长期安全性数据不足"
          ]
        },
        {
          "hypothesis_id": "H8",
          "score": 0.34,
          "components": {
            "mechanism_fit": 0.6,
            "class_prior": 0.5,
            "pk_pd_feasibility": 0.7,
            "indication_plausibility": 0.5,
            "safety_risk": 0.5,
            "graph_bonus": 0,
            "conflict_penalty": 0.8
          },
          "graph_signals": {
            "support_weight": 0.6,
            "contradiction_weight": 0.8,
            "mechanistic_connectivity": false,
            "path_disjointness": 1,
            "conflict_hotspots": [
              {
                "topic": "Adverse effects in Epileptic encephalopathy",
                "pro": [
                  "n_zonisamide"
                ],
                "con": [
                  "H8"
                ]
              }
            ]
          },
          "rationales": {
            "mechanism_fit": [
              "支持 Zonisamide 禁忌用于重度癫痫，文献支持"
            ],
            "safety_risk": [
              "Skeptic 指出风险路径与不良反应之间的关系"
            ]
          },
          "confidence": "medium",
          "uncertainties": [
            "需要更多证据确认具体禁忌机制",
            "Zonisamide 的长期安全性数据不足"
          ]
        },
        {
          "hypothesis_id": "H9",
          "score": 0.32,
          "components": {
            "mechanism_fit": 0.6,
            "class_prior": 0.5,
            "pk_pd_feasibility": 0.7,
            "indication_plausibility": 0.5,
            "safety_risk": 0.5,
            "graph_bonus": 0,
            "conflict_penalty": 0.8
          },
          "graph_signals": {
            "support_weight": 0.5,
            "contradiction_weight": 0.8,
            "mechanistic_connectivity": false,
            "path_disjointness": 1,
            "conflict_hotspots": [
              {
                "topic": "Adverse effects in Epileptic encephalopathy",
                "pro": [
                  "n_pregabalin"
                ],
                "con": [
                  "H9"
                ]
              }
            ]
          },
          "rationales": {
            "mechanism_fit": [
              "支持 Pregabalin 禁忌用于重度癫痫，文献支持"
            ],
            "safety_risk": [
              "Skeptic 指出风险路径与不良反应之间的关系"
            ]
          },
          "confidence": "medium",
          "uncertainties": [
            "需要更多证据确认具体禁忌机制",
            "Pregabalin 的长期安全性数据不足"
          ]
        },
        {
          "hypothesis_id": "H10",
          "score": 0.32,
          "components": {
            "mechanism_fit": 0.6,
            "class_prior": 0.5,
            "pk_pd_feasibility": 0.7,
            "indication_plausibility": 0.5,
            "safety_risk": 0.5,
            "graph_bonus": 0,
            "conflict_penalty": 0.8
          },
          "graph_signals": {
            "support_weight": 0.5,
            "contradiction_weight": 0.8,
            "mechanistic_connectivity": false,
            "path_disjointness": 1,
            "conflict_hotspots": [
              {
                "topic": "Adverse effects in Epileptic encephalopathy",
                "pro": [
                  "n_gabapentin"
                ],
                "con": [
                  "H10"
                ]
              }
            ]
          },
          "rationales": {
            "mechanism_fit": [
              "支持 Gabapentin 禁忌用于重度癫痫，文献支持"
            ],
            "safety_risk": [
              "Skeptic 指出风险路径与不良反应之间的关系"
            ]
          },
          "confidence": "medium",
          "uncertainties": [
            "需要更多证据确认具体禁忌机制",
            "Gabapentin 的长期安全性数据不足"
          ]
        },
        {
          "hypothesis_id": "H11",
          "score": 0.3,
          "components": {
            "mechanism_fit": 0.6,
            "class_prior": 0.5,
            "pk_pd_feasibility": 0.7,
            "indication_plausibility": 0.5,
            "safety_risk": 0.5,
            "graph_bonus": 0,
            "conflict_penalty": 0.8
          },
          "graph_signals": {
            "support_weight": 0.4,
            "contradiction_weight": 0.8,
            "mechanistic_connectivity": false,
            "path_disjointness": 1,
            "conflict_hotspots": [
              {
                "topic": "Adverse effects in Epileptic encephalopathy",
                "pro": [
                  "n_rufinamide"
                ],
                "con": [
                  "H11"
                ]
              }
            ]
          },
          "rationales": {
            "mechanism_fit": [
              "支持 Rufinamide 禁忌用于重度癫痫，文献支持"
            ],
            "safety_risk": [
              "Skeptic 指出风险路径与不良反应之间的关系"
            ]
          },
          "confidence": "medium",
          "uncertainties": [
            "需要更多证据确认具体禁忌机制",
            "Rufinamide 的长期安全性数据不足"
          ]
        },
        {
          "hypothesis_id": "H12",
          "score": 0.3,
          "components": {
            "mechanism_fit": 0.6,
            "class_prior": 0.5,
            "pk_pd_feasibility": 0.7,
            "indication_plausibility": 0.5,
            "safety_risk": 0.5,
            "graph_bonus": 0,
            "conflict_penalty": 0.8
          },
          "graph_signals": {
            "support_weight": 0.4,
            "contradiction_weight": 0.8,
            "mechanistic_connectivity": false,
            "path_disjointness": 1,
            "conflict_hotspots": [
              {
                "topic": "Adverse effects in Epileptic encephalopathy",
                "pro": [
                  "n_clobazam"
                ],
                "con": [
                  "H12"
                ]
              }
            ]
          },
          "rationales": {
            "mechanism_fit": [
              "支持 Clobazam 禁忌用于重度癫痫，文献支持"
            ],
            "safety_risk": [
              "Skeptic 指出风险路径与不良反应之间的关系"
            ]
          },
          "confidence": "medium",
          "uncertainties": [
            "需要更多证据确认具体禁忌机制",
            "Clobazam 的长期安全性数据不足"
          ]
        }
      ]
    },
    "thresholds": {
      "stop_delta": 0.03,
      "saturation_ratio": 0.65,
      "weights": {
        "path_disjointness": 1.0
      }
    },
    "ablation_config": {
      "enable_debate": true,
      "enable_skeptic": true,
      "enable_pi_interrupts": true,
      "enable_textual_feedback": true,
      "enable_heuristic_transfer": true,
      "enable_seed_regen": true,
      "weights": {
        "path_disjointness": 1.0
      },
      "mode": "graph"
    }
  },
  "output": {
    "revisions": [
      {
        "hypothesis_id": "H1",
        "graph_actions": [
          {
            "type": "stress_test_safety",
            "topic": "Phenytoin的长期安全性",
            "expectation": "检验Phenytoin对重度癫痫患者的长期不良反应数据",
            "assignee": "Skeptic"
          },
          {
            "type": "add_mechanism_link",
            "from": "Phenytoin",
            "via": [],
            "to": "Epileptic Encephalopathy",
            "success_criteria": "确认至少一条与不良反应相关的机制路径",
            "assignee": "Proponent"
          }
        ],
        "debate_focus": [
          "检验Phenytoin在重度癫痫患者中的实际应用案例",
          "探讨Phenytoin的禁忌机制及其真实影响"
        ]
      },
      {
        "hypothesis_id": "H2",
        "graph_actions": [
          {
            "type": "stress_test_safety",
            "topic": "Carbamazepine的长期安全性",
            "expectation": "检验Carbamazepine对重度癫痫患者的长期不良反应数据",
            "assignee": "Skeptic"
          },
          {
            "type": "add_mechanism_link",
            "from": "Carbamazepine",
            "via": [],
            "to": "Epileptic Encephalopathy",
            "success_criteria": "确认至少一条与不良反应相关的机制路径",
            "assignee": "Proponent"
          }
        ],
        "debate_focus": [
          "检验Carbamazepine在重度癫痫患者中的实际应用案例",
          "探讨Carbamazepine的禁忌机制及其真实影响"
        ]
      },
      {
        "hypothesis_id": "H3",
        "graph_actions": [
          {
            "type": "stress_test_safety",
            "topic": "Valproate的长期安全性",
            "expectation": "检验Valproate对重度癫痫患者的长期不良反应数据",
            "assignee": "Skeptic"
          },
          {
            "type": "add_mechanism_link",
            "from": "Valproate",
            "via": [],
            "to": "Epileptic Encephalopathy",
            "success_criteria": "确认至少一条与不良反应相关的机制路径",
            "assignee": "Proponent"
          }
        ],
        "debate_focus": [
          "检验Valproate在重度癫痫患者中的实际应用案例",
          "探讨Valproate的禁忌机制及其真实影响"
        ]
      },
      {
        "hypothesis_id": "H4",
        "graph_actions": [
          {
            "type": "stress_test_safety",
            "topic": "Lamotrigine的长期安全性",
            "expectation": "检验Lamotrigine对重度癫痫患者的长期不良反应数据",
            "assignee": "Skeptic"
          },
          {
            "type": "add_mechanism_link",
            "from": "Lamotrigine",
            "via": [],
            "to": "Epileptic Encephalopathy",
            "success_criteria": "确认至少一条与不良反应相关的机制路径",
            "assignee": "Proponent"
          }
        ],
        "debate_focus": [
          "检验Lamotrigine在重度癫痫患者中的实际应用案例",
          "探讨Lamotrigine的禁忌机制及其真实影响"
        ]
      },
      {
        "hypothesis_id": "H5",
        "graph_actions": [
          {
            "type": "stress_test_safety",
            "topic": "Topiramate的长期安全性",
            "expectation": "检验Topiramate对重度癫痫患者的长期不良反应数据",
            "assignee": "Skeptic"
          },
          {
            "type": "add_mechanism_link",
            "from": "Topiramate",
            "via": [],
            "to": "Epileptic Encephalopathy",
            "success_criteria": "确认至少一条与不良反应相关的机制路径",
            "assignee": "Proponent"
          }
        ],
        "debate_focus": [
          "检验Topiramate在重度癫痫患者中的实际应用案例",
          "探讨Topiramate的禁忌机制及其真实影响"
        ]
      }
    ],
    "seed_request": {
      "should_regenerate": true,
      "reason": "机制连通性不足，且支持与冲突权重均较高，需要补充新的候选药物",
      "n": 4
    }
  }
}